Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-30

Clinical Trial Update: Alzheimer's Disease Long-term Follow-up Study (ALF Study) [Phase 4]

View source ↗

Summary

Phase 4 long-term follow-up study update for Alzheimer’s disease completed; no new results provided in snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED